Skip to main content

Genetics Startups

Updated November 2026

Companies in the genetics sector developing innovative solutions and technologies.

Explore 352 recently funded genetics companies with verified founder contact information and fundraising data.

Total Companies
352
Total Funding
$546.4M
Avg Funding
$21.9M
Global Reach
10
countries

Top Cities for Genetics

Copenhagen
San Francisco
Boston
Edinburgh
Waltham
London

Recently Funded Companies

Export
Copenhagen, Denmark

Sidera Bio harness human genetics, that helps in transformative medicines for patients.

$109.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.

$200.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Medici Therapeutics is a biotechnology company that offers gene therapy.

$14.8M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Edinburgh, United Kingdom

We aim to transform how miRNAs are detected, providing simpler tools for health care and drug development professionals.

$2.6M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Waltham, United States

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

$3.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Spin-out of Imperial College London developing ground-breaking vector and pest control solutions for a healthier and more sustainable world

$12.8M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.

$400K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Shannon, Ireland

Altratech Limited designs biosensors and semiconductor chips for DNA testing of food traceability for agri business.

$441K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Kelowna, Canada

Rize Oncology develops a platform that allows to conjugate or tether donor DNA templates.

$358K raised
Oct 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Enabling Safer Gene Editing

$3.5M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Milano, Italy

Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.

$15.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.

$31.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Nome is the Operating System for Personalized Therapies™ — developing custom treatments for rare disease patients, families, and clinicians.

$2.7M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Perlara, PBC is precision drug discovery that leaves no mutation behind.

$1.7M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Waltham, United States

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.

$40.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Nottingham, United Kingdom

Forge Genetics is a startup with proprietary Forge Editing technology, bypassing CRISPR patents for precision gene-editing services.

$2.7M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Dallas, United States

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

$29.4M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Nionyx Bio builds AAV-based gene therapies to address some of the most potent kidney genetic diseases.

$4.0M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Redefining Sample Preparation, Revolutionizing Genomics

$300K raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

$53.0M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Barcelona, Spain

Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.

$3.2M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Lausanne, Switzerland

HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.

Sep 2025

Founder Contacts

41,000+ verified contacts

Ishikawa, Japan

Fermelanta is a biotech firm that produces rare plant-based ingredients through microbial fermentation.

$13.6M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Gaithersburg, United States

Polaris Genomics identifies genomic biomarkers to support the development of psychiatric drugs and clinical tools.

$250K raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Barueri, Brazil

Bioma Genetics is a genomic and microbiota testing startup that specializes in human genetics and microbiome for patients.

$2.7M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Showing 101 to 125 of 352 companies

About the Genetics Startup Ecosystem

The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Genetics

Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Genetics Funding Breakdown

Here is how funding is distributed among the 352 genetics companies tracked in the VCBacked database.

Average Funding
$21.9M
Total Funding Tracked
$546.4M
Countries Represented
10

Distribution by Funding Stage

Other25 companies

Top Cities for Genetics

1.Boston
3 companies$98.8M
2.San Francisco
2 companies$201.7M
3.Waltham
2 companies$43.0M
4.New York
2 companies$7.5M
5.San Diego
2 companies$3.0M

Related Industries

Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Genetics Startups?

Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked